NR-RP-K002

N/A

Report date: 2025/09/05 17:15:24
NME

Base Information

Drug NameNR-RP-K002
Drug Alias NameNR-RP-K002
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCicatrix, HypertrophicObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoRegen Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeoRegen Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsCicatrix, HypertrophicObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A